European Archives of Psychiatry and Clinical Neuroscience,
Journal Year:
2023,
Volume and Issue:
273(7), P. 1513 - 1525
Published: Feb. 14, 2023
Cognitive
impairment
has
been
observed
in
patients
with
various
psychiatric
disorders,
including
schizophrenia,
major
depressive
disorder
(MDD),
and
bipolar
(BD).
Although
modern
therapeutic
drugs
can
improve
certain
symptoms
(i.e.,
psychosis,
depression)
these
patients,
have
not
found
to
cognitive
impairment.
The
N-methyl-D-aspartate
receptor
antagonist
(R,S)-ketamine
attracted
attention
as
a
rapidly
acting
antidepressant.
In
addition
its
robust
antidepressant
effects,
suggested
MDD
BD,
despite
causing
healthy
control
subjects.
is
racemic
mixture
of
equal
amounts
(R)-ketamine
(or
arketamine)
(S)-ketamine
esketamine).
Arketamine
more
potent
antidepressant-like
actions
than
esketamine
rodents.
Interestingly,
arketamine,
but
esketamine,
phencyclidine-induced
deficits
mice.
Furthermore,
arketamine
ameliorate
rodent
offspring
after
maternal
immune
activation.
the
current
article,
it
proposed
that
potential
for
treating
disorders.
Additionally,
role
gut-microbiome-brain
axis
disorders
discussed.
BMC Public Health,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Jan. 2, 2024
Evidence
on
the
association
between
multimorbidity
and
cognitive
impairment
in
Chinese
older
population
is
limited.
In
addition,
whether
a
healthy
lifestyle
can
protect
function
multimorbid
remains
unknown.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Feb. 20, 2024
Various
microbial
communities
reside
in
the
gastrointestinal
tract
of
humans
and
play
an
important
role
immunity,
digestion,
drug
metabolism,
intestinal
integrity,
protection
from
pathogens.
Recent
studies
have
revealed
that
gut
microbiota
(GM)
is
involved
communication
with
brain,
through
a
bidirectional
network
known
as
gut-brain
axis.
This
involves
humoral,
immunological,
endocrine,
neural
pathways.
Gut
dysbiosis
negatively
impacts
these
pathways,
leading
to
neurological
complications
cognitive
deficits.
Both
pre-clinical
clinical
demonstrated
probiotics
can
restore
healthy
GM,
reduce
pH,
inflammation
pathogenic
microbes
gut.
Additionally,
improve
cell-to-cell
signaling
increase
blood-brain-derived
neurotrophic
factors.
Probiotics
emerge
potential
approach
for
preventing
managing
Despite
promising
findings,
safety
concerns
possible
risks
probiotic
usage
must
be
closely
monitored
addressed.
review
article
provides
brief
overview
significance
health.
Critical Reviews in Food Science and Nutrition,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 22
Published: Feb. 5, 2025
Alcohol
abuse-triggered
alcohol-related
liver
disease
(ALD)
has
become
as
a
global
public
health
concern
that
substantially
affects
the
well-being
and
clinical
status
of
patients.
Although
modern
medicine
provides
various
treatments
for
ALD,
their
effectiveness
is
limited
can
lead
to
adverse
side
effects.
Probiotics
have
been
employed
prevent,
alleviate,
even
treat
with
promising
results.
However,
few
comprehensive
reviews
are
available
on
how
they
mitigate
ALD
by
targeting
gut-liver
axis.
This
review
systematically
clarifies
specific
mediators
axis
in
healthy
states.
It
also
describes
alterations
observed
ALD.
Furthermore,
this
thoroughly
summarizes
underlying
mechanisms
through
which
probiotics
act
relieve
discusses
current
challenges
faced
research
applications.
Finally,
we
discuss
future
prospects
using
improves
our
understanding
supports
development
application
target
therapeutic
use.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(9), P. e30426 - e30426
Published: April 26, 2024
The
brain
is
sensitive
to
oxidative
stress,
which
can
trigger
microglial
activation
and
neuroinflammation.
Antioxidant
therapies
may
provide
neuroprotection
against
stress.
In
recent
years
antioxidant
effects
of
probiotics
their
possible
mechanisms
in
stress-related
models
have
been
determined.
the
current
study,
for
first
time,
we
assessed
OBM Neurobiology,
Journal Year:
2025,
Volume and Issue:
09(01), P. 1 - 12
Published: Feb. 28, 2025
Interactions
in
the
gut-brain
crosstalk
have
led
to
development
of
an
entirely
new
concept:
"microbiota-gut-brain
axis".
Microbiota
has
gained
considerable
attention
relation
disorders
a
more
neurological
nature,
such
as
neurodevelopmental
and
neuropsychiatric
illnesses
like
autism
spectrum
disorder,
anxiety,
mood
disorders.
This
review
aims
summarize
recent
trends
insights
into
role
consequences
gut
microbiota
brain
health
pediatric
Dysbiosis
may
be
associated
with
increased
risk
diseases
that
lead
different
disruptions
conditions,
including
mental
issues.
During
dysbiosis,
neuropsychological
stress
hormones
usually
affect
oxytocin
GABA
neurons
are
significantly
reduced.
Current
studies
report
major
depression,
cognitive
dysfunction
closely
dysbiosis.
In
last
few
years,
handful
clinical
emerged,
illustrating
potential
for
bidirectional
relationship
interactions
humans.
Perhaps
some
most
crucial
investigations
demonstrating
overlapping
relationships
human
axis
come
from
trials
focusing
on
modulating
noting
significant
correlates.
A
field
is
emerging
gene-editing
technology
could
represent
tool
improve
microbial
characteristics.
approach
particularly
relevant
neurodegenerative
brain-gut
linked
loss
species
and/or
high
pathobiont
load.
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
12
Published: April 9, 2025
Vitamin
D
is
known
to
have
a
potential
impact
on
cognitive
function
and
mental
health.
This
study
aims
assess
the
association
between
dietary
vitamin
intake
performance,
as
well
depression,
in
an
elderly
U.S.
population.
Data
from
National
Health
Nutrition
Examination
Survey
(NHANES)
2013-2014
were
analyzed.
A
total
of
1,344
participants
categorized
into
three
tertiles
based
their
(D2
+
D3).
Cognitive
was
measured
using
Consortium
Establish
Registry
for
Alzheimer's
Disease
(CERAD)
test,
Digit
Symbol
Substitution
Test
(DSST),
Animal
Fluency
Test,
while
depression
assessed
through
Patient
Questionnaire-9
(PHQ-9).
Adjustments
made
confounding
variables,
including
age,
sex,
race,
education,
physical
activity
level,
other
factors.
After
adjustment
confounders,
individuals
3rd
tertile
(≥4.9
mcg/day)
had
significantly
reduced
odds
low
performance
CERAD
test
(OR:
0.77,
95%
CI:
0.57-0.98;
p
=
0.031)
0.63,
0.49-0.85;
0.013)
compared
1st
(≤2.4
mcg/day).
Similarly,
lower
(PHQ-9
score
>
4)
after
0.68,
0.48-0.99;
0.046).
Our
findings
suggest
that
associated
with
improved
depressive
symptoms
individuals.
However,
further
longitudinal
studies
are
needed
establish
causality
explore
underlying
mechanisms.